help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fardella, C. E.
Right arrow Articles by Montero, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fardella, C. E.
Right arrow Articles by Montero, J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*DEXAMETHASONE
*FLUDROCORTISONE
*SODIUM
Medline Plus Health Information
*High Blood Pressure
The Journal of Clinical Endocrinology & Metabolism Vol. 85, No. 5 1863-1867
Copyright © 2000 by The Endocrine Society

Original Studies

Primary Hyperaldosteronism in Essential Hypertensives: Prevalence, Biochemical Profile, and Molecular Biology1

Carlos E. Fardella, Lorena Mosso, Celso Gómez-Sánchez, Paola Cortés, Julia Soto, Luis Gómez, Mauricio Pinto, Alvaro Huete, Eveline Oestreicher, A. Foradori and JoaquÍn Montero

Departments of Endocrinology (C.E.F., L.M., P.C., L.G., M.P., E.O.), Internal Medicine (J.M.), Radiology (A.H.), and The Associated Unit of Clinical Laboratories (J.S., A.F.), Faculty of Medicine, Catholic University of Chile, Marcoleta 391, Santiago, Chile; and Endocrine Section (C.G.-S.), Harry S. Truman Memorial Hospital, Department of Internal Medicine, Columbia, Missouri 65201-5297

Address correspondence and requests for reprints to: Carlos E. Fardella, Department of Endocrinology, Faculty of Medicine, P. Universidad Católica de Chile, Marcoleta 391, Santiago, Chile.

There is evidence that primary aldosteronism (PA) may be common in patients with essential hypertension (EH) when determinations of serum aldosterone (SA), plasma renin activity (PRA), and the SA/PRA ratio are used as screening. An inherited form of primary hyperaldosteronism is the glucocorticoid-remediable aldosteronism (GRA) caused by an unequal crossing over between the CYP11B1 and CYP11B2 genes that results in a chimeric gene, which has aldosterone synthase activity regulated by ACTH. The aim of this study was to evaluate the prevalence of PA and the GRA in 305 EH patients and 205 normotensive controls. We measured SA (1–16 ng/dL) and PRA (1–2.5 ng/mL·h) and calculated the SA/PRA ratio in all patients. A SA/PRA ratio level greater than 25 was defined as being elevated. PA was diagnosed in the presence of high SA levels (>16 ng/dL), low PRA levels (<0.5 ng/mL·h), and very high SA/PRA ratio (>50). Probable PA was diagnosed when the SA/PRA ratio was more than 25 but the other criteria were not present. A Fludrocortisone test was done to confirm the diagnosis. GRA was differentiated from other forms of PA by: the aldosterone suppression test with dexamethasone, the high levels of 18-hydroxycortisol, and the genetic detection of the chimeric gene. In EH patients, 29 of 305 (9.5%) had PA, 13 of 29 met all the criteria for PA, and 16 of 29 were initially diagnosed as having a probable PA and confirmed by the fludrocortisone test. Plasma potassium was normal in all patients. The dexamethasone suppression test was positive for GRA in 10 of 29 and 18-hydroxycortisol levels were high in 2 of 29 patients who had also a chimeric gene. In normotensive subjects, 3 of 205 (1.46%) had PA, and 1 of 205 had a GRA. In summary, we found a high frequency of normokalemic PA in EH patients. A high proportion of PA suppressed SA with dexamethasone, but only a few had a chimeric gene or high levels of 18-hydroxycortisol. These results emphasize the need to further investigate EH patients.




This article has been cited by other articles:


Home page
 ANN INTERN MEDHome page
M. J.E. Kempers, J. W.M. Lenders, L. van Outheusden, G. J. van der Wilt, L. J. Schultze Kool, A. R.M.M. Hermus, and J. Deinum
Systematic Review: Diagnostic Procedures to Differentiate Unilateral From Bilateral Adrenal Abnormality in Primary Aldosteronism
Ann Intern Med, September 1, 2009; 151(5): 329 - 337.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
G. J. Becker, T. D. Hewitson, and A. Chrysostomou
Aldosterone in clinical nephrology--old hormone, new questions
Nephrol. Dial. Transplant., August 1, 2009; 24(8): 2316 - 2321.
[Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
P. R. Grimm, D. L. Irsik, D. C. Settles, J. D. Holtzclaw, and Steven. C. Sansom
Hypertension of Kcnmb1-/- is linked to deficient K secretion and aldosteronism
PNAS, July 14, 2009; 106(28): 11800 - 11805.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
N. Sukor, R. D. Gordon, Y. K. Ku, M. Jones, and M. Stowasser
Role of Unilateral Adrenalectomy in Bilateral Primary Aldosteronism: A 22-Year Single Center Experience
J. Clin. Endocrinol. Metab., July 1, 2009; 94(7): 2437 - 2445.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
E. Born-Frontsberg, M. Reincke, L. C. Rump, S. Hahner, S. Diederich, R. Lorenz, B. Allolio, J. Seufert, C. Schirpenbach, F. Beuschlein, et al.
Cardiovascular and Cerebrovascular Comorbidities of Hypokalemic and Normokalemic Primary Aldosteronism: Results of the German Conn's Registry
J. Clin. Endocrinol. Metab., April 1, 2009; 94(4): 1125 - 1130.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Lampron, I. Bourdeau, S. Oble, A. Godbout, W. Schurch, P. Arjane, P. Hamet, and A. Lacroix
Regulation of Aldosterone Secretion by Several Aberrant Receptors Including for Glucose-Dependent Insulinotropic Peptide in a Patient with an Aldosteronoma
J. Clin. Endocrinol. Metab., March 1, 2009; 94(3): 750 - 756.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
A. Karagiannis, K. Tziomalos, A. I Kakafika, V. G Athyros, F. Harsoulis, and D. P Mikhailidis
Medical treatment as an alternative to adrenalectomy in patients with aldosterone-producing adenomas
Endocr. Relat. Cancer, September 1, 2008; 15(3): 693 - 700.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. W. Funder, R. M. Carey, C. Fardella, C. E. Gomez-Sanchez, F. Mantero, M. Stowasser, W. F. Young Jr., and V. M. Montori
Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline
J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3266 - 3281.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
P. Mulatero
A New Form of Hereditary Primary Aldosteronism: Familial Hyperaldosteronism Type III
J. Clin. Endocrinol. Metab., August 1, 2008; 93(8): 2972 - 2974.
[Full Text] [PDF]

Home page
 CirculationHome page
D. A. Calhoun, D. Jones, S. Textor, D. C. Goff, T. P. Murphy, R. D. Toto, A. White, W. C. Cushman, W. White, D. Sica, et al.
Resistant Hypertension: Diagnosis, Evaluation, and Treatment: A Scientific Statement From the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research
Circulation, June 24, 2008; 117(25): e510 - e526.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
D. A. Calhoun, D. Jones, S. Textor, D. C. Goff, T. P. Murphy, R. D. Toto, A. White, W. C. Cushman, W. White, D. Sica, et al.
Resistant Hypertension: Diagnosis, Evaluation, and Treatment: A Scientific Statement From the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research
Hypertension, June 1, 2008; 51(6): 1403 - 1419.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
L. A. Davies, C. Hu, N. A. Guagliardo, N. Sen, X. Chen, E. M. Talley, R. M. Carey, D. A. Bayliss, and P. Q. Barrett
TASK channel deletion in mice causes primary hyperaldosteronism
PNAS, February 12, 2008; 105(6): 2203 - 2208.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
E. Pimenta, K. K. Gaddam, M. N. Pratt-Ubunama, M. K. Nishizaka, I. Aban, S. Oparil, and D. A. Calhoun
Relation of Dietary Salt and Aldosterone to Urinary Protein Excretion in Subjects With Resistant Hypertension
Hypertension, February 1, 2008; 51(2): 339 - 344.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
N. Makhanova, J. Hagaman, H.-S. Kim, and O. Smithies
Salt-Sensitive Blood Pressure in Mice With Increased Expression of Aldosterone Synthase
Hypertension, January 1, 2008; 51(1): 134 - 140.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
D. A. Calhoun and N. M. Kaplan
Is There an Unrecognized Epidemic of Primary Aldosteronism? (Pro)
Hypertension, September 1, 2007; 50(3): 447 - 453.
[Full Text] [PDF]

Home page
 HypertensionHome page
N. M. Kaplan and D. A. Calhoun
Is There an Unrecognized Epidemic of Primary Aldosteronism? (Con)
Hypertension, September 1, 2007; 50(3): 454 - 458.
[Full Text] [PDF]

Home page
 HypertensionHome page
G. P. Rossi, A. Belfiore, G. Bernini, G. Desideri, B. Fabris, C. Ferri, G. Giacchetti, C. Letizia, M. Maccario, F. Mallamaci, et al.
Comparison of the Captopril and the Saline Infusion Test for Excluding Aldosterone-Producing Adenoma
Hypertension, August 1, 2007; 50(2): 424 - 431.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
S. J. Hood, K. P. Taylor, M. J. Ashby, and M. J. Brown
The Spironolactone, Amiloride, Losartan, and Thiazide (SALT) Double-Blind Crossover Trial in Patients With Low-Renin Hypertension and Elevated Aldosterone-Renin Ratio
Circulation, July 17, 2007; 116(3): 268 - 275.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
G. E. Umpierrez, P. Cantey, D. Smiley, A. Palacio, D. Temponi, K. Luster, and A. Chapman
Primary Aldosteronism in Diabetic Subjects With Resistant Hypertension
Diabetes Care, July 1, 2007; 30(7): 1699 - 1703.
[Abstract] [Full Text] [PDF]

Home page
 RadioGraphicsHome page
S. M. Patel, R. K. Lingam, T. I. Beaconsfield, T. L. Tran, and B. Brown
Role of Radiology in the Management of Primary Aldosteronism
RadioGraphics, July 1, 2007; 27(4): 1145 - 1157.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
O. Vonend, C. Altenhenne, N. J. Buchner, G. Dekomien, C. Maser-Gluth, S. M. Weiner, L. Sellin, S. Hofebauer, J. T. Epplen, and L. C. Rump
A German family with glucocorticoid-remediable aldosteronism
Nephrol. Dial. Transplant., April 1, 2007; 22(4): 1123 - 1130.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
N. Chapman, J. Dobson, S. Wilson, B. Dahlof, P. S. Sever, H. Wedel, N. R. Poulter, and on behalf of the Anglo-Scandinavian Cardiac Outcom
Effect of Spironolactone on Blood Pressure in Subjects With Resistant Hypertension
Hypertension, April 1, 2007; 49(4): 839 - 845.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
M. Barr, S. M. MacKenzie, E. C. Friel, C. D. Holloway, D. M. Wilkinson, N. J.R. Brain, M. C. Ingram, R. Fraser, M. Brown, N. J. Samani, et al.
Polymorphic Variation in the 11{beta}-Hydroxylase Gene Associates With Reduced 11-Hydroxylase Efficiency
Hypertension, January 1, 2007; 49(1): 113 - 119.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
G. P. Rossi, G. Bernini, C. Caliumi, G. Desideri, B. Fabris, C. Ferri, C. Ganzaroli, G. Giacchetti, C. Letizia, M. Maccario, et al.
A Prospective Study of the Prevalence of Primary Aldosteronism in 1,125 Hypertensive Patients
J. Am. Coll. Cardiol., December 5, 2006; 48(11): 2293 - 2300.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
D. A. Calhoun
Aldosteronism and Hypertension
Clin. J. Am. Soc. Nephrol., September 1, 2006; 1(5): 1039 - 1045.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
C. Schirpenbach, L. Seiler, C. Maser-Gluth, F. Beuschlein, M. Reincke, and M. Bidlingmaier
Automated Chemiluminescence-Immunoassay for Aldosterone during Dynamic Testing: Comparison to Radioimmunoassays with and without Extraction Steps
Clin. Chem., September 1, 2006; 52(9): 1749 - 1755.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
P. Mulatero, A. Milan, F. Fallo, G. Regolisti, F. Pizzolo, C. Fardella, L. Mosso, L. Marafetti, F. Veglio, and M. Maccario
Comparison of Confirmatory Tests for the Diagnosis of Primary Aldosteronism
J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2618 - 2623.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
F. E. Nwariaku, B. S. Miller, R. Auchus, S. Holt, L. Watumull, B. Dolmatch, S. Nesbitt, W. Vongpatanasin, R. Victor, F. Wians, et al.
Primary Hyperaldosteronism: Effect of Adrenal Vein Sampling on Surgical Outcome
Arch Surg, May 1, 2006; 141(5): 497 - 503.
[Abstract] [Full Text] [PDF]

Home page
 QJMHome page
A. Karagiannis, K. Tziomalos, K. Dona, A. Pyrpasopoulou, N. Kartali, V. Athyros, and C. Zamboulis
Bilateral renal artery stenosis and primary aldosteronism in a diabetic patient
QJM, December 1, 2005; 98(12): 913 - 915.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Stowasser, J. Sharman, R. Leano, R. D. Gordon, G. Ward, D. Cowley, and T. H. Marwick
Evidence for Abnormal Left Ventricular Structure and Function in Normotensive Individuals with Familial Hyperaldosteronism Type I
J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5070 - 5076.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
G. L. Schwartz and S. T. Turner
Screening for Primary Aldosteronism in Essential Hypertension: Diagnostic Accuracy of the Ratio of Plasma Aldosterone Concentration to Plasma Renin Activity
Clin. Chem., February 1, 2005; 51(2): 386 - 394.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S.-C. Tiu, C.-H. Choi, C.-C. Shek, Y.-W. Ng, F. K. W. Chan, C.-M. Ng, and A. P. S. Kong
The Use of Aldosterone-Renin Ratio as a Diagnostic Test for Primary Hyperaldosteronism and Its Test Characteristics under Different Conditions of Blood Sampling
J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 72 - 78.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
O. Olivieri, A. Ciacciarelli, D. Signorelli, F. Pizzolo, P. Guarini, C. Pavan, A. Corgnati, S. Falcone, R. Corrocher, A. Micchi, et al.
Aldosterone to Renin Ratio in a Primary Care Setting: The Bussolengo Study
J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4221 - 4226.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
F. H. Perschel, R. Schemer, L. Seiler, M. Reincke, J. Deinum, C. Maser-Gluth, D. Mechelhoff, R. Tauber, and S. Diederich
Rapid Screening Test for Primary Hyperaldosteronism: Ratio of Plasma Aldosterone to Renin Concentration Determined by Fully Automated Chemiluminescence Immunoassays
Clin. Chem., September 1, 2004; 50(9): 1650 - 1655.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
E. M. Freel and J. M.C. Connell
Mechanisms of Hypertension: The Expanding Role of Aldosterone
J. Am. Soc. Nephrol., August 1, 2004; 15(8): 1993 - 2001.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
P. Mulatero, M. Stowasser, K.-C. Loh, C. E. Fardella, R. D. Gordon, L. Mosso, C. E. Gomez-Sanchez, F. Veglio, and W. F. Young Jr.
Increased Diagnosis of Primary Aldosteronism, Including Surgically Correctable Forms, in Centers from Five Continents
J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1045 - 1050.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
D. A. Calhoun, M. K. Nishizaka, M. A. Zaman, and S. M. Harding
Aldosterone Excretion Among Subjects With Resistant Hypertension and Symptoms of Sleep Apnea
Chest, January 1, 2004; 125(1): 112 - 117.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
E. A. Espiner, D. G. Ross, T. G. Yandle, A. M. Richards, and P. J. Hunt
Predicting Surgically Remedial Primary Aldosteronism: Role of Adrenal Scanning, Posture Testing, and Adrenal Vein Sampling
J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3637 - 3644.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
L. Mosso, C. Carvajal, A. Gonzalez, A. Barraza, F. Avila, J. Montero, A. Huete, A. Gederlini, and C. E. Fardella
Primary Aldosteronism and Hypertensive Disease
Hypertension, August 1, 2003; 42(2): 161 - 165.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
W. F. Young Jr.
Minireview: Primary Aldosteronism--Changing Concepts in Diagnosis and Treatment
Endocrinology, June 1, 2003; 144(6): 2208 - 2213.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
D. A. Calhoun, M. K. Nishizaka, M. A. Zaman, R. B. Thakkar, and P. Weissmann
Hyperaldosteronism Among Black and White Subjects With Resistant Hypertension
Hypertension, December 1, 2002; 40(6): 892 - 896.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
P. Mulatero, F. Rabbia, A. Milan, C. Paglieri, F. Morello, L. Chiandussi, and F. Veglio
Drug Effects on Aldosterone/Plasma Renin Activity Ratio in Primary Aldosteronism
Hypertension, December 1, 2002; 40(6): 897 - 902.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
P. Mulatero, S. M. di Cella, T. A. Williams, A. Milan, G. Mengozzi, L. Chiandussi, C. E. Gomez-Sanchez, and F. Veglio
Glucocorticoid Remediable Aldosteronism: Low Morbidity and Mortality in a Four-Generation Italian Pedigree
J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3187 - 3191.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
P. Mulatero, T. A. Williams, A. Milan, C. Paglieri, F. Rabbia, F. Fallo, and F. Veglio
Blood Pressure in Patients with Primary Aldosteronism Is Influenced by Bradykinin B2 Receptor and {alpha}-Adducin Gene Polymorphisms
J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3337 - 3343.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
O. L. Castro, X. Yu, and D. C. Kem
Diagnostic Value of the Post-Captopril Test in Primary Aldosteronism
Hypertension, April 1, 2002; 39(4): 935 - 938.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
A. R. Carter, Z. H. Zhou, D. A. Calhoun, and J. K. Bubien
Hyperactive ENaC identifies hypertensive individuals amenable to amiloride therapy
Am J Physiol Cell Physiol, November 1, 2001; 281(5): C1413 - C1421.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. E. Fardella, M. Pinto, L. Mosso, C. Gomez-Sanchez, J. Jalil, and J. Montero
Genetic Study of Patients with Dexamethasone-Suppressible Aldosteronism without the Chimeric CYP11B1/CYP11B2 Gene
J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4805 - 4807.
[Abstract] [Full Text] [PDF]

Home page
 Journal of Renin-Angiotensin-Aldosterone SystemHome page
M. Stowasser, R. D Gordon, J. C Rutherford, N. Z Nikwan, N. Daunt, and G. J Slater
Review: Diagnosis and management of primary aldosteronism
Journal of Renin-Angiotensin-Aldosterone System, September 1, 2001; 2(3): 156 - 169.
[PDF]

Home page
 HypertensionHome page
L. Mosso, C. E. Gomez-Sanchez, M. F. Foecking, and C. Fardella
Serum 18-Hydroxycortisol in Primary Aldosteronism, Hypertension, and Normotensives
Hypertension, September 1, 2001; 38(3): 688 - 691.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. E. Fardella and L. Mosso
Authors' Response: Prevalence of Primary Aldosteronism in Unselected Hypertensive Populations--Screening and Definitive Diagnosis
J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 4003 - 4004.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Ganguly
Prevalence of Primary Aldosteronism in Unselected Hypertensive Populations: Screening and Definitive Diagnosis
J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 4002 - 4003.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2000 by The Endocrine Society